Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Color Diagnostics, |
RCV001525640 | SCV001735814 | likely benign | Familial hypercholesterolemia | 2020-07-14 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV004008859 | SCV004836441 | likely benign | Hypercholesterolemia, autosomal dominant, 3 | 2023-11-20 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004037975 | SCV005030895 | likely benign | Cardiovascular phenotype | 2023-11-21 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
GENin |
RCV001525640 | SCV005627223 | likely benign | Familial hypercholesterolemia | 2025-01-10 | criteria provided, single submitter | clinical testing | This is a synonymous (silent) variant that is not predicted to impact splicing and occurs at a nucleotide which is not highly conserved. This variant has been classified as Likely Benign (BP4, BP7). |